The government backed Newborn Bloodspot Screening (NBS) program has successfully found two cases of Congenital Adrenal Hyperplasia (CAH) in Victorian babies since starting screening in July this year.
Screening for a genetic condition that affects the adrenal glands, and if left untreated can cause sudden death in infants, will be developed in 2021-22 as part of the Newborn Bloodspot Screening (NBS) Program in Victoria.
In 2016, Victoria is celebrating 50 years of the newborn bloodspot screening program. Based at The Royal Children’s Hospital in Melbourne, The Victorian Clinical Genetics Services (VCGS) plays a vital role in this program. VCGS operates the screening laboratory for the State and has analysed nearly 80,000 newborn bloodspot samples in 2015.